UK HTA Body To Conduct More Appraisals, And Faster, Through Proportionate Approach
Faced with the rise in its workload, the UK’s health technology assessment body NICE is exploring ways of tailoring its approach to appraisals according to the type of product under consideration.
You may also be interested in...
NICE, the health technology appraisal body for England, has published an interim process and methods guide for its new proportionate approach to HTAs.
Ngenla and Ofev are the first two drugs to be evaluated using the health technology appraisal institute’s new proportionate approach – they were both appraised much faster than usual.
Many pharma firms are considering cutting their investment in clinical trials or reducing their supply to the UK market next year, a survey by industry group EMIG found.